Pilot study to assess increased dialysis efficiency in patients with limited blood flow rates due to vascular access problems

Salvatore Mandolfo, Sabrina Borlandelli, Enrico Imbasciati, Salvatore Badalamenti, Giorgio Graziani, Luisa Sereni, Michele Varesani, Mary Loise Wratten, Alessandro Corsi, Attilio Elli

Research output: Contribution to journalArticlepeer-review

Abstract

In the last few years, the number of hemodialysis patients with inadequate blood flow (Qb) rates has increased due to vascular access problems. To avoid a clinical status of underdialysis, these patients need long-lasting dialysis sessions. However, other factors aimed to optimize the dialysis dose have to be considered. High-efficiency convective therapies, such as online hemodiafiltration (HDF), are claimed to be superior to high-flux hemodialysis (HF-HD) in improving the dialysis efficacy, but treatment efficacy is strongly related to blood flow rate and infusion volumes. Online mid-dilution (HDF-MD) with the Nephros OL-pure MD190 represents a new HDF concept to increase the removal of middle molecules. In a cross-over clinical trial, 8 patients, with Qb eff 2-microglobulin (β 2 m), and leptin (L) solutes was significantly greater for MD (P 217 ± 32, β 2m 85.5 ± 10, L 42.6 ± 18mL/min) than for HF-HD (P 178 ± 32, β 2m 71.9 ± 13, L 32.1 ± 12mL/min). The results of this study indicate that HDF remains the best means of providing increased removal of large-molecular weight solutes even in patients with vascular access problems.

Original languageEnglish
Pages (from-to)55-61
Number of pages7
JournalHemodialysis International
Volume12
Issue number1
DOIs
Publication statusPublished - Jan 2008

Keywords

  • β2 m
  • Blood flow rate
  • Dialysis efficiency
  • Leptin

ASJC Scopus subject areas

  • Hematology

Fingerprint

Dive into the research topics of 'Pilot study to assess increased dialysis efficiency in patients with limited blood flow rates due to vascular access problems'. Together they form a unique fingerprint.

Cite this